新里程：公司积极应对医保支付方式改革

Core Insights - The company reported a 4 percentage point decrease in drug cost ratio for its hospitals in the first three quarters, now standing at 36% [2] - Despite the reduction in drug cost ratio, the supply chain profit margin remained stable year-on-year [2] - The company has actively responded to the reform of medical insurance payment methods, leading to a 3 percentage point increase in effective revenue ratio during the same period [2]